Skip to content
HealthNew techTop 11% of today's analysed ideas

Side-effect tracker for GLP-1 drug users

Build a lightweight companion app for GLP-1 drug users (Ozempic, Wegovy, Mounjaro) that logs side effects like hair loss, brittle nails, and muscle loss, and nudges users on protein, biotin, collagen, and vitamin intake to offset nutrient deficiencies. Target the large, vocal online community of GLP-1 users already swapping tips about these exact symptoms, and monetize through subscription or supplement affiliate links.

Original post

What to build

A mobile app for GLP-1 drug users (Ozempic, Wegovy, Mounjaro) that logs hair, nail, and muscle-loss symptoms over time, correlates them with dose/diet entries, and nudges users on daily protein, biotin, collagen, and vitamin intake to offset nutrient deficiencies.

Hair loss was the first widely reported GLP-1 side effect; nail brittleness is now surfacing as a second, related cosmetic/nutrient-deficiency symptom, and the same vocal online user base swapping remedies is a ready-made audience for a tracking and coaching app.

Demand

GLP-1 users experiencing rapid weight loss and visible cosmetic side effects are already trading tips in forums and groups; the Gizmodo piece on nail trouble getting strong Hacker News engagement signals this is spreading beyond a niche complaint into broader awareness.

  • Hacker NewsNews

    'Hair Loss Was Just the Start. Ozempic Users Are Also Reporting Nail Trouble' — 45 points, 38 comments on HN, indicating high engagement with the topic among a tech-savvy audience.

  • Signal title source (unspecified outlet)News

    Media coverage framing nail trouble as an emerging secondary side effect pattern among GLP-1 users, following earlier widely-reported hair loss coverage.

  • Online GLP-1 user community (implied)Anecdotal

    Opportunity brief notes a 'large, vocal online community of GLP-1 users already swapping tips' on hair loss, brittle nails, and muscle loss, pointing to active peer-to-peer demand for solutions.

Stack

  • React Native / Expo
  • Supabase (auth + Postgres for symptom/dose logs)
  • RevenueCat (subscription billing)
  • OpenAI API (symptom-pattern summaries and reminders copy)
  • Amazon Associates / iHerb affiliate API (supplement links)
  • Push notifications (Expo Notifications) for daily nutrient nudges

Solo + AI difficulty

The core build is easy for a solo AI-assisted developer: symptom logging, dose tracking, and reminder notifications are standard CRUD + push-notification patterns shippable in 2-4 weeks. The harder parts are get the supplement/nutrient guidance content right without making implied medical claims, and building enough trust (and retention hooks like trend charts) to beat free Reddit/Facebook groups as the default place people go.

Entry threshold
A solo builder can ship a simple tracking and reminder app with AI-assisted development in two to four weeks using off-the-shelf health-tracker templates; no medical license is needed since it is informational rather than diagnostic, but content must avoid medical claims.
Window
12-18 months

Where to find first users

  • r/Ozempic, r/Semaglutide, r/Mounjaro, r/WegovyWeightLoss subreddits
  • GLP-1 Facebook support groups
  • TikTok/Instagram creators covering Ozempic side effects
  • Product Hunt launch targeting health and weight-loss tools

Counter-signals & risks

  • Anecdotal self-reported symptoms on forums/social media are not clinically validated and may not reflect true prevalence or causation from GLP-1 drugs versus rapid weight loss or caloric deficit generally.

  • A companion/logging app faces low switching cost and competition from existing general health-tracking apps, nutrition apps, and free online communities (Reddit, Facebook groups) already serving this need.

  • Regulatory and liability risk around app-driven supplement recommendations (biotin, collagen, protein) for a population on prescription medication, especially if marketed with implied medical claims.

Original title: Hair Loss Was Just the Start. Ozempic Users Are Also Reporting Nail Trouble

  • Health#4

    Outbreak compliance and alert tools for schools

    Build a lightweight compliance and alert tool for school nurses, daycare operators and pediatric clinics that tracks immunization status, flags unvaccinated students during active outbreaks, and auto-generates exemption and exposure-notification paperwork required as states tighten reporting after the elimination status loss. Pair it with a simple consumer app that pulls public CDC and state outbreak data to tell parents and travelers if they are in an exposed area and whether a booster is recommended.

    Demand
    3/10
    measured
    Buildability
    7/10
    est.
    Competition
    6/10
    est.
    via Hacker News
    33 competitors
  • Health#4

    Bypass tool for Withings' new Apple Health paywall

    Build a small utility or app that pulls weight, sleep and body-composition data from a user's Withings account via its API and pushes it into Apple Health or Google Fit directly, letting new Withings owners keep free health-data syncing without paying the new $99 per year subscription. Target the wave of annoyed new Withings buyers discussing the change on Reddit and tech forums, and extend it into a broader multi-device health-data aggregator once the first version proves demand.

    Demand
    9/10
    measured
    Buildability
    7/10
    est.
    Competition
    7/10
    est.
    via Hacker News
    22 competitors
  • Health#11

    Influencer-led growth clone for niche nutrition apps

    Clone the Cal AI playbook (photo-to-calories AI logging plus an influencer-first TikTok and Instagram growth strategy) but point it at an underserved health-tracking niche instead of general calorie counting, for example macro tracking for lifters, carb counting for diabetics, or nutrition tracking for pregnancy or specific diets. The product itself is a thin AI vision wrapper; the real asset being copied is the creator-driven acquisition model that took Cal AI to 30 million dollars in two years and an acquisition by MyFitnessPal.

    Demand
    7/10
    est.
    Buildability
    7/10
    est.
    Competition
    5/10
    est.
    via TechCrunch
    44 competitors
Side-effect tracker for GLP-1 drug users — Nichr